Thailand Medical Cannabis Market Size, Share and Forecast to 2027
a month ago
3 min read

Thailand Medical Cannabis Market Size, Share and Forecast to 2027

According to IMARC Group’s latest report, titled “Thailand Medical Cannabis Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, offers a comprehensive analysis of the industry, which comprises insights on the Thailand medical cannabis market trends.

The Thailand medical cannabis market size reached US$ 79 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 1,195 Million by 2027, exhibiting a CAGR of 55.6% during 2022-2027. Medical cannabis is derived from the Cannabis sativa plant that is primarily used to ease symptoms caused by medical conditions. Tetrahydrocannabinol (THC) is the main psychoactive part of cannabis that is used for medicinal purposes across the globe. Cancer, anorexia, muscle spasms, nausea, Alzheimer’s, Crohn’s disease, epilepsy, Tourette’s, and post-traumatic stress disorder (PTSD) are some of the medical conditions that can be treated using medical cannabis. In Thailand, medical cannabis is extensively used as traditional medicine, a condiment in cooking, and for several medical purposes, such as easing labor pains and muscle relaxers.

Get a Free Sample Copy of this Report: https://www.imarcgroup.com/thailand-medical-cannabis-market/requestsample

Thailand Medical Cannabis Market Trends:

The primary factor driving the medical cannabis market in Thailand is the legalization of the product for medical purposes. Additionally, the country is backed by the annual tropical climate that is considered ideal for cannabis cultivation, further resulting in lower production costs. In line with this, key market players are heavily investing in establishing their manufacturing facilities in Thailand due to the climatic advantage, which is providing a significant boost to the market growth. Moreover, rapid technological advancements and the increasing prevalence of chronic diseases are accelerating the market growth. Other factors, such as the rising number of clinical trials, surging investments in research and development (R&D) activities, and the rapidly growing geriatric population, are creating a positive outlook for the market.

Competitive Landscape With Key Players:

The competitive landscape of the thailand medical cannabis market has been studied in the report with the detailed profiles of the key players operating in the market.

Key Market Segmentation:

The report has segmented the thailand medical cannabis market on the basis of cultivated species, derivatives, application areas, end-use and route of administration.

Breakup by Cultivated Species:

  • Indica

  • Sativa

  • Hybrid

Breakup by Derivatives:

  • Cannabidiol (CBD)

  • Tetrahydrocannabinol (THC)

  • Others

Breakup by Application Areas:

  • Cancer

  • Arthritis

  • Migraine

  • Epilepsy

  • Others

Breakup by End-Use:

  • Pharmaceuticals

  • Research and Development Centres

  • Others

Breakup by Route of Administration:

  • Oral Solutions and Capsules

  • Vaporizers

  • Topicals

  • Others

Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/thailand-medical-cannabis-market

Key Highlights of the Report:

  • Market Performance (2016-2021)

  • Market Outlook (2022-2027)

  • Market Trends

  • Market Drivers and Success Factors

  • Impact of COVID-19

  • Value Chain Analysis

  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact US:

IMARC Group

30 N Gould St, Ste R

Sheridan, WY 82801, USA

Website: https://www.imarcgroup.com/

Email: sales@imarcgroup.com

Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800